[Congressional Bills 113th Congress] [From the U.S. Government Publishing Office] [S. 2338 Enrolled Bill (ENR)] S.2338 One Hundred Thirteenth Congress of the United States of America AT THE SECOND SESSION Begun and held at the City of Washington on Friday, the third day of January, two thousand and fourteen An Act To reauthorize the United States Anti-Doping Agency, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
S 2338 - 113
Enrolled Bill
United States Anti-Doping Agency Reauthorization Act
6
Sections
7
Dollar amounts
0
Deadlines and effective dates
N/A
Text version date
Largest fiscal amounts
$14,800,000 1
$14,100,000 1
$13,500,000 1
$12,900,000 1
$12,300,000 1
$11,700,000 1
$11,300,000 1
Top statutory references
21 U.S.C. 2001 1
21 U.S.C. 2003 1
Official source
Official PDF
Preview the source PDF from the official text formats without leaving this page, or open the original file in a new tab.
Structured text
Sec. 1.
SECTION 1. SHORT TITLE.
SECTION 1. SHORT TITLE. This Act may be cited as the ``United States Anti-Doping Agency Reauthorization Act''.
Sec. 2.
SEC. 2. PROHIBIT PERFORMANCE-ENHANCING METHODS.
SEC. 2. PROHIBIT PERFORMANCE-ENHANCING METHODS.
Sec. 701
Section 701 of title VII of the Office of National Drug Control
Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended-- (1) in subsection (a), by striking paragraph (4); and (2) in subsection (b)-- (A) in paragraph (1), by inserting ``and be recognized worldwide as the independent national anti-doping organization for the United States'' after ``Committee''; (B) in paragraph (2), by striking ``, or performance- enhancing genetic modifications accomplished through gene- doping'' and inserting ``or prohibited performance-enhancing methods adopted by the Agency''; (C) in paragraph (3), by striking ``, or performance- enhancing genetic modifications accomplished through gene- doping'' and inserting ``or prohibited performance-enhancing methods adopted by the Agency''; (D) in paragraph (4), by striking ``and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and'' and inserting ``, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency.''; and (E) by striking paragraph (5).
Sec. 3.
SEC. 3. AUTHORIZATION OF APPROPRIATIONS.
SEC. 3. AUTHORIZATION OF APPROPRIATIONS.
Sec. 703
Section 703 of title VII of the Office of National Drug Control
Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to read as follows: ``SEC. 703. AUTHORIZATION OF APPROPRIATIONS. ``There are authorized to be appropriated to the United States Anti-Doping Agency-- ``(1) for fiscal year 2014, $11,300,000; ``(2) for fiscal year 2015, $11,700,000; ``(3) for fiscal year 2016, $12,300,000; ``(4) for fiscal year 2017, $12,900,000; ``(5) for fiscal year 2018, $13,500,000; ``(6) for fiscal year 2019, $14,100,000; and ``(7) for fiscal year 2020, $14,800,000.''. Speaker of the House of Representatives. Vice President of the United States and President of the Senate.
Cached official text analysis. This viewer uses cached official bill text and deterministic section, phrase, fiscal, agency, deadline, and statutory-reference extraction. The analysis is navigation support, not a legal interpretation; consult the official text for authoritative wording.
Sign in to use bill text research tools
Text find, signal filters, structured drilldowns, match navigation, and bill text bookmarks are account features. Create a free account to use them and return to this bill text.